The Interagency Council on Biomedical Imaging (ICBIO) in Oncology brings together technology developers and representatives from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Centers for Medicare and Medicaid Services (CMS) to expedite the process of bringing new products to market, to provide advice from a multi-agency perspective on the spectrum of scientific, regulatory, and reimbursement issues related to developing imaging devices or technology. The Request to Present form and further information can be found on the next page.
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®